Most Recent
Difflam maker sues Reckitt Benckiser over ads for rival Strepfen lozenges
The Australian maker of Difflam has taken UK consumer goods giant Reckitt Benckiser to court over ads for Strepfen that claim the rival lozenges provide 'longer lasting relief' from sore throats.
Squire Patton Boggs must pay rival’s fees for fighting GetSwift restraint
Law firm Squire Patton Boggs is again on the losing end of a ruling by the judge presiding over a shareholder class action against GetSwift, a case now better known for infighting among lawyers than for the allegations levelled against the tech startup.
Lawsuits pile up against Macquarie over financial adviser commissions
Macquarie Bank is facing a fourth lawsuit by a group of former financial advisers alleging it breached the Fair Work Act by denying them regular wages.
Goodyear files appeal in trade mark fight with rival Dunlop
US tyre company Goodyear wants to challenge a ruling in a long-running dispute with UK-based rival Dunlop over coveted trade marks for 'Dunlop' and 'Flying D'.
BHP wants judge to stay Australian class action over Brazil disaster
A judge on Friday will hear arguments in a bid by BHP Billiton to halt a class action over the mining giant's Brazilian mine disaster, a sweeping case filed on behalf of investors who held the company's shares in Australia, the UK or South Africa.
Myer class action funder must pay $1M in security for trial
The litigation funder underwriting a class action against Myer will have to fork over another $950,000 in security ahead of what will be a rare shareholder trial starting next Wednesday, a court has ruled.
Debt collector ACM harassed stroke victim, court finds
One of Australia's largest debt collectors, ACM Group, harassed and coerced vulnerable customers -- including a stroke victim -- by bombarding them with phone calls and making empty threats of litigation, the Federal Court found Monday.
No holds barred in GetSwift class action challenge
The naming of Squire Patton Boggs as a concurrent wrongdoer in GetSwift’s defence puts the law firm in an “impossible position of conflict of interest” if it wins a challenge to an order staying its class action against the company, the Full Federal Court has been told ahead of a highly anticipated appeal hearing that promises to pull no punches.
Privilege not waived by DLA Piper phone call over Circadin patent
Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals' patents covering sleep drug Circadin, with a court ruling legal professional privilege was waived in a phone conversation between a DLA Piper lawyer and the company's founder.
Surfstitch shareholders get hands on ASIC transcripts
Investors in a class action against failed online retailer Surfstitch Group won access Thursday to transcripts of interviews of former boss Justin Cameron by the corporate watchdog.